HomeInsightsMarket Capitalization

Market Capitalization of Orchid Pharma Ltd

Market Capitalization of Orchid Pharma Ltd

stocks purchased

₹ 1.5 Cr

Volume transacted

stocks purchased

10.5 K

stocks traded

Last Updated time: 16 Sep 15:30 PM

Image

Orchid Pharma Ltd

NSE: ORCHPHARMA

MARKETCAP

7489.44 crore

Last updated: 16 Sep 24

Key Highlights

  • The Market Cap of Orchid Pharma Ltd is ₹ 7489 crore as of 16 Sep 24.
  • The Market Cap of Orchid Pharma Ltd changed from ₹ 47.42 crore on March 2019 to ₹ 5301 crore on March 2024 . This represents a CAGR of 119.48% over 6 years. .
  • The Latest Trading Price of Orchid Pharma Ltd is ₹ 1476 as of 16 Sep 15:30.

Historical Market Cap of Orchid Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Orchid Pharma Ltd

No data available

Image

Orchid Pharma Ltd

NSE: ORCHPHARMA

PRICE

1476.65

-54.95 (-3.59%)

stock direction

Last updated: 16 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Orchid Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
16 Sep 20241476.65
13 Sep 20241531.6
12 Sep 20241517.55
11 Sep 20241509.75
10 Sep 20241508.75
09 Sep 20241470.25
06 Sep 20241490.45
05 Sep 20241458.05
04 Sep 20241385.95
03 Sep 20241411.75

SWOT Analysis Of Orchid Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Orchid Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Orchid Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Orchid Pharma Ltd677,489
Sun Pharmaceuticals Industries Ltd424,46,984
Divis Laboratories Ltd861,45,453
Cipla Ltd301,34,028
Torrent Pharmaceuticals Ltd691,16,845
Zydus Lifesciences Ltd261,12,261

Key Valuation Metric of Orchid Pharma Ltd

No data available

Historical P/E Ratio of Orchid Pharma Ltd

No data available

* All values are in %

Historical Revenue of Orchid Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Orchid Pharma Ltd

No data available

* All values are in %

About Orchid Pharma Ltd

  • Orchid Pharma Ltd., is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries.
  • Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
  • The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai.
  • The Company is a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well as in drug discovery, which was incorporated on 1st July 1992 as a 100% Export Oriented Unit (EOU).

Orchid Pharma Ltd News Hub

News

Orchid Pharma announces board meeting date

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 20...

Read more

10 Aug 202412:49

News

Orchid Pharma to conduct AGM

Orchid Pharma announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

18 Jul 202420:35

News

Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam

Cefepime-Enmetazobactam has been approved for the treatment of complicated urinary tract i...

Read more

29 Jun 202410:08

News

Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India

Orchid Pharma announced the launch of its new drug - Cefepime-Enmetazobactam, which has be...

Read more

28 Jun 202419:23

News

Orchid Pharma receives DCGI approval for Enmetazobactam

Orchid Pharma has received Drugs Controller General of India (DCGI) approval for the manuf...

Read more

06 Jun 202413:06

News

Orchid Pharma gains on DCGI nod for new antibiotic drug combination

DCGI has also granted permission to manufacture and market finished dosage form (FDF) of C...

Read more

06 Jun 202412:38

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Orchid Pharma Ltd

What is the market cap of Orchid Pharma Ltd?

As of September 16, 2024, Orchid Pharma Ltd has a market capitalization of ₹7489.44, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Orchid Pharma Ltd's market capitalization?

Orchid Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Orchid Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Orchid Pharma Ltd's market capitalization change?

Orchid Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*